Summary
An erythrocyte pyrimidine 5′-nucleotidase (P5N) test was performed for 171 workers occupationally exposed to lead. Erythrocyte P5N activity was markedly inhibited by exposure to lead. Among several biological indicators (erythrocyte P5N, δ-aminolevulinic acid dehydratase (ALAD), protoporphyrin (PROTO), urinary δ-aminolevulinic acid (ALA), coproporphyrin (COPRO)), the P5N activity had the highest correlation with the concentration of lead in blood (r = − 0.77). A significant inhibition of erythrocyte P5N was found in groups of lead workers with blood-lead levels of more than 10 to 19 μg/dl. This P5N inhibition started before any changes occurred in urinary ALA and COPRO. A 45 to 50% inhibition of P5N corresponded to the blood-lead value (50 μg/dl) of the BEI recommended by ACGIH. In some lead workers, erythrocyte nucleotides (mainly CTP and UTP) were determined. The data indicated that a marked accumulation of these nucleotides had occurred, and their levels correlated negatively with P5N activity and positively with blood lead.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
ACGIH (1988) Documentation of the biological exposure indices for 1987–1988
Adair CG, Elder GE, Lappin TRJ, Bridges JM, Nelson MG (1988) Red cell pyrimidine 5′-nucleotidase deficiency: determination of nucleotidase activity and nucleotide content using HPLC. Clin Chim Acta 171:75–84
Albahary C (1972) Lead and hemopoiesis: the mechanism and consequences of the erythropathy of occupational lead poisoning. Am J Med 52:367–378
Angle CR, McIntire MS (1978) Low level lead and inhibition of erythrocyte pyrimidine nucleotidase. Environ Res 17:296–302
Angle CR, Stohs SJ, McIntire MS, Swanson MS, Rovang KS (1980) Lead-induced accumulation of erythrocyte pyrimidine nucleotides in the rabbit. Toxicol Appl Pharmacol 54:161–167
Buc HA, Kaplan JC (1978) Red-cell pyrimidine 5′-nucleotidase and lead poisoning. Clin Chim Acta 87:49–55
Cook LR, Angle CR, Kubitschek CE, Stohs SJ (1987) Prediction of blood lead by HPLC assay of erythrocyte pyrimidine 5′-nucleotidase. J Anal Toxicol 11:39–42
Cook LR, Angle CR, Stohs SJ (1986) Erythrocyte arginase, pyrimidine 5′-nucleotidas (P5N) and deoxypyrimidine 5′-nucleotidase (dP5N) as indices of lead exposure. Br J Ind Med 43:387–390
Cook LR, Schafer-Mitchell M, Angle CR, Stohs SJ (1985) Assay of human erythrocyte pyrimidine and deoxypyrimidine 5′-nucleotidase by isocratic reversed-phase high-performance liquid chromatography. J Chromatogr 339:293–301
Higaki T, Kagimoto T, Nagata K, Tanase S, Morino Y, Takatsuki K (1984)31P and1H nuclear magnetic resonance studies of erythrocytes from a patient with pyrimidine 5′-nucleotidase deficiency. Biomed Res 5:321–328
Ichiba M, Tomokuni K (1988) Response of erythrocyte pyrimidine 5′-nucleotidase (P5N) activity in workers exposed to lead. Br J Ind Med 45:718–719
Ichiba M, Tomokuni K, Sugimoto K (1987) Erythrocyte pyrimidine 5′-nucleotidase test for occupational lead exposure. Ind Health 25:195–204
Mohammed-Brahim B, Buchet JP, Lauwerys R (1985) Erythrocyte pyrimidine 5′-nucleotidase activity in workers exposed to lead, mercury or cadmium. Int Arch Occup Environ Health 55:247–252
Nikkanen J, Hernberg S, Tola S (1972) Modifications of the delta-aminolevulinic acid dehydratase test and their significance for assessing different intensities of lead exposure. Work Environ Health 9:46–52
Paglia DE, Valentine WN (1975) Characteristics of a pyrimidine-specific 5′-nucleotidase in human erythrocytes. J Biol Chem 250:7973–7979
Paglia DE, Valentine WN, Dahlgren JG (1975) Effects of low level lead exposure on pyrimidine 5′-nucleotidase and other erythrocyte enzymes. J Clin Invest 56:1164–1169
Parpart AK, Lorenz PB, Parpart ER, Gregg JR, Chase AM (1947) The osmotic resistance (fragility) of human red cells. J Clin Invest 26:636–640
Piomelli S (1973) A micromethod for erythrocyte porphyrins; the FEP test. J Lab Clin Med 81:932–940
Rocco R, Smart JL, Brown DR, Blumberg JB (1981) HPLC analysis of erythrocyte pyrimidine-5′-nucleotidase inhibition by lead. Res Comm Chem Pathol Pharmacol 34:127–136
Sakai T, Ushio K (1986) A simplified method for determining erythrocyte pyrimidine 5′-nucleotidase (P5N) activity by HPLC and its value in monitoring lead exposure. Br J Ind Med 43:839–844
Sakai T, Araki T, Ushio K (1988) Determination of pyrimidine 5′-nucleotidase (P5N) activity in whole blood as an index of lead exposure. Br J Ind Med 45:420–425
Sakai T, Yanagihara S, Ushio K (1982) Determination of 5′-nucleotidase activity in human erythrocytes and plasma using high-performance liquid chromatography. J Chromatogr 239:717–721
Sano S (1955) Studies on the nature of basophilic stippled cell in lead poisoning. Report 1. Studies on the cytological investigation of basophilic stippled cell. Acta Haematol Jpn 18:625–630
Swanson MS, Angle CR, Stohs SJ, Rovang KS (1980) Erythrocyte nucleotides from control and lead-treated rabbits. Res Comm Chem Pathol Pharmacol 27:353–361
Tomokuni K, Hirai Y (1986) Simple liquid-chromatographic determination of urinary coproporphyrin in workers exposed to lead. Clin Chem 32:872–873
Tomokuni K, Ichiba M (1986) Simple determination of erythrocyte pyrimidine 5′-nucleotidase activity in human blood by high-performance liquid chromatography. Ind Health 24:227–233
Tomokuni K, Ogata M (1972) Simple method for determination of urinary δ-aminolevulinic acid as an index of lead exposure. Clin Chem 18:1534–1536
Tomokuni K, Ichiba M, Hirai Y, Hasegawa T, Sugimoto K (1988) Relationship between inhibition of erythrocyte pyrimidine 5′-nucleotidase activity and biological response for porphyrin metabolism in workers occupationally exposed to lead. Int Arch Occup Environ Health 60:431–436
Torrance J, West C, Beutler E (1977) A simple rapid radiometric assay for pyrimidine 5′-nucleotidase. J Lab Clin Med 90:563–568
Torrance J, Mills W, Kilroe-Smith TA, Smith AN (1985) Erythrocyte pyrimidine 5′-nucleotidase activity as a sensitive indicator of lead exposure. S Afr Med J 67:850–852
Valentine WN, Fink K, Paglia DE, Harris SR, Adams WS (1974) Hereditary hemolytic anemia with human erythrocyte pyrimidine 5′-nucleotidase deficiency. J Clin Invest 54:866–879
Vives-Corrons JL, Montserrat-Costa E, Rozman C (1976) Hereditary hemolytic anemia with erythrocyte pyrimidine 5′-nucleotidase deficiency in Spain. Hum Genet 34:285–292
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ichiba, M., Tomokuni, K. Studies on erythrocyte pyrimidine 5′-nucleotidase (P5N) test and its evaluation in workers occupationally exposed to lead. Int. Arch Occup Environ Heath 62, 305–310 (1990). https://doi.org/10.1007/BF00640838
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00640838